If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSoftcat Regulatory News (SCT)

Share Price Information for Softcat (SCT)

Share Price is delayed by 15 minutes
Get Live Data
1,835.00    -84.00 (-4.38%)
Bid:
1,825.00
Ask:
1,827.00
Spread: 2.00 (0.11%)
Market Cap: £3.60b
SCT Live PriceLast checked at - London Stock Exchange

Intraday Softcat Share Chart

Partnership with Wilden AG

27 Sep 2006 07:00

Screen Technology Group plc27 September 2006 For Immediate Release 27 September 2006 Screen Technology Group plc ("Screen Technology" or "the Company") Technical and financial partnership with Wilden AG Screen Technology Group plc ("Screen Technology" or "the Company" or "theGroup") the designer and manufacturer of revolutionary high-resolutionlarge-screen displays for high ambient light environments today announces anexciting new technical and financial partnership with Wilden AG. Highlights • Long-term supply arrangement for Wilden to supply injection moulded light-guides to Screen Technology.• Wilden will set up a production "cell" to produce light guides and operate Screen Technology's tile assembly machine to produce finished tiles.• Wilden will provide funds to acquire the first high-speed machine and provide long-term finance of the injection moulding tools.• Total investment by Wilden totalling over £1.2 million and over £500,000 by the beginning of 2007.• The partnership will accelerate Screen Technology's expansion of production resources.• Potential for Wilden to reproduce further production cells in locations around the world.• Wilden has the technical competence, financial resources and global reach to be a valuable partner for Screen Technology for the future. Peter Smyth, non-executive Chairman said "We are very excited by the partnership with Wilden AG, which will give us astrengthened platform for growth. Wilden, has the technical competence, theresources and the global reach to be a valuable partner and the investmentWilden is putting into the partnership will give us a greater ability to expandto meet expected market demands." Technical and financial partnership Screen Technology is pleased to announce that it has signed letters of intentwith Wilden AG ("Wilden") to enter into a partnership for the production ofinjection moulded light guides and the operation of the Company's first highspeed tile assembly machine. Wilden is a major producer of specialist high-quality high-technology injectionmouldings for the automotive, electronic and telecommunications and medicalindustries. Its customers include Daimler Chrysler, Astra Zeneca, Siemens,Sennheiser and Roche. Wilden has a broad international presence with facilitieslocated in North America, Western and Eastern Europe, and the Middle and FarEast. The agreement provides that Wilden will manufacture two new injection mouldingtools to produce light guides for use in the manufacture of ITrans tiles. Thecost of these tools will be spread over three years. Furthermore, Wilden has agreed to fund the acquisition of the first high speedtile assembly machine when it completes its factory acceptance testing, expectedto be in October of this year. Wilden will provide cash to meet the finalpayment due on the delivery of the machine with further payments amounting tothe full £1.1 million cost of the machine. Wilden's total contribution to thecost of moulding tools and the tile assembly machine is expected to amount toover £500,000 by the beginning of next year. In addition, Wilden will investitself in dedicated injection moulding machinery to produce the light guides ona 24/7 basis. Wilden will operate the tile assembly machine at its own premises on a sub-contract basis although the machine and all the intellectual property that goeswith the ITrans process will continue to belong to Screen Technology. The boardexpects this production "cell" making light guides and ITrans tiles at onelocation to be a model for more cells which may be located around the world. This partnership is a very exciting opportunity for Screen Technology. InWilden, we have found a partner with the technical competence and the resourcesand global reach to work with us through a period of rapid expansion.Furthermore the investment that Wilden is putting into this project in time andresources as well as significant cash commitment underlines the faith we bothhave in the success of ITrans. For more information please contact Screen Technology Group plc www.screentechnology.comThomas Jarman, CEO 01223 559600Simon Barton, Finance Director Buchanan Communications 020 74665000Isabel Podda Notes to Editors Screen Technology is the designer and manufacturer of revolutionaryhigh-resolution large-screen displays designed for high ambient lightenvironments. The high resolution and high definition of the Company's displays give ahigh-quality image suitable for advertising images and video as well as publicinformation displays. They are visible at short viewing distances as well asacross larger venues making them particularly suitable for large retail outlets,shopping malls, control rooms and transport concourses where customers might bewithin 10m of the display, a distance at which LED display technologies becomeunsuitable. The high brightness means that the displays are also easily visiblein the kind of high ambient light environments where conventional LCD or plasmatechnologies become unusable. Screen Technology's patent protected technology uses moulded optical fibre tilesto produce seamless large displays using standard production LCD panels. Thescaleable modular technology enables screens to be built in a wide variety ofshapes and of theoretically unlimited size. Screen Technology Group plc listed on AIM, a market operated by the London StockExchange, on 1 August 2005. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
21st Jan 20265:12 pmRNSTransaction in Own Shares
20th Jan 20265:42 pmRNSTransaction in Own Shares
19th Jan 20265:33 pmRNSTransaction in Own Shares
16th Jan 20265:16 pmRNSTransaction in Own Shares
15th Jan 20265:29 pmRNSTransaction in Own Shares
14th Jan 20265:35 pmRNSTransaction in Own Shares
13th Jan 20265:29 pmRNSTransaction in Own Shares
12th Jan 20265:33 pmRNSTransaction in Own Shares
9th Jan 20266:21 pmRNSTransaction in Own Shares
8th Jan 20266:31 pmRNSTransaction in Own Shares
8th Jan 20262:03 pmRNSDirector/PDMR Shareholding
8th Jan 20267:00 amRNSShare Buyback Programme
2nd Jan 202610:21 amRNSTotal Voting Rights
22nd Dec 202512:25 pmRNSDirector/PDMR Shareholding
22nd Dec 202512:25 pmRNSDirector/PDMR Shareholding
16th Dec 20251:15 pmRNSResult of AGM
15th Dec 20254:02 pmRNSDirector/PDMR Shareholding
12th Dec 20251:06 pmRNSDirector/PDMR Shareholding
10th Dec 202511:18 amRNSDirector/PDMR Shareholding
10th Dec 202511:09 amRNSDirector/PDMR Shareholding
28th Nov 20251:47 pmRNSDirector/PDMR Shareholding
28th Nov 20251:41 pmRNSDirector/PDMR Shareholding
25th Nov 202510:43 amRNSAdditional Listing
18th Nov 20257:00 amRNSQ1 2026 Trading Update
13th Nov 202511:04 amRNSBlock listing Interim Review
11th Nov 20252:29 pmRNSDirector/PDMR Shareholding
5th Nov 20251:15 pmRNSAnnual Financial Report
3rd Nov 20252:37 pmRNSTotal Voting Rights
22nd Oct 20257:00 amRNSPreliminary Results
9th Oct 20252:48 pmRNSDirector/PDMR Shareholding
23rd Sep 202510:57 amRNSHolding(s) in Company
9th Sep 20251:46 pmRNSDirector/PDMR Shareholding
28th Aug 20257:00 amRNSYear End Trading Update
11th Aug 20258:48 amRNSDirector/PDMR Shareholding
9th Jul 20259:24 amRNSDirector/PDMR Shareholding
1st Jul 20259:21 amRNSTotal Voting Rights
10th Jun 20253:07 pmRNSDirector/PDMR Shareholding
2nd Jun 20254:30 pmRNSTotal Voting Rights
28th May 20257:00 amRNSQ3 2025 Trading Update
27th May 20259:14 amRNSDirector Declaration
15th May 20259:39 amRNSBlock listing Interim Review
9th May 202512:58 pmRNSDirector/PDMR Shareholding
1st May 20253:41 pmRNSTotal Voting Rights
8th Apr 20252:46 pmRNSDirector/PDMR Shareholding
7th Apr 20259:00 amRNSAcquisition of Oakland Group Services Ltd
1st Apr 202511:35 amRNSTotal Voting Rights
19th Mar 20257:00 amRNSHalf-year Report
13th Mar 20259:52 amRNSHolding(s) in Company
10th Mar 20252:13 pmRNSDirector/PDMR Shareholding
3rd Mar 202510:41 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.